Willow Biosciences Inc. (WLLW.TO)
CAD 0.06
(-20.0%)
CAD 0.06
(-20.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -11.06 Million CAD | 24.76% |
| 2022 | -12.08 Million CAD | 21.02% |
| 2021 | -2.92 Million CAD | -44.85% |
| 2020 | -30.72 Million CAD | -25.13% |
| 2019 | -43.93 Million CAD | -575.5% |
| 2018 | -1.59 Million CAD | -156.84% |
| 2017 | -1.83 Million CAD | 26.17% |
| 2016 | -842.84 Thousand CAD | -655.04% |
| 2015 | -1.31 Million CAD | 87.1% |
| 2014 | -865.25 Thousand CAD | 10.14% |
| 2013 | -1.38 Million CAD | -54.0% |
| 2012 | -625.24 Thousand CAD | 32.51% |
| 2011 | -926.36 Thousand CAD | 4.47% |
| 2010 | -969.71 Thousand CAD | 51.11% |
| 2009 | -3.21 Million CAD | -78.6% |
| 2008 | -1.35 Million CAD | 46.39% |
| 2007 | -2.04 Million CAD | -392.3% |
| 2006 | -420.82 Thousand CAD | 4.93% |
| 2005 | -442.64 Thousand CAD | -128.57% |
| 2004 | -193.65 Thousand CAD | -1576.28% |
| 2003 | 13.11 Thousand CAD | 118.71% |
| 2002 | -70.1 Thousand CAD | 57.74% |
| 2001 | -165.86 Thousand CAD | 7.84% |
| 2000 | -179.96 Thousand CAD | -57.27% |
| 1999 | -114.43 Thousand CAD | 43.38% |
| 1998 | -202.12 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.1 Million CAD | 1.79% |
| 2024 Q2 | -1.09 Million CAD | 44.34% |
| 2023 Q2 | -3.2 Million CAD | 27.2% |
| 2023 Q1 | -4.4 Million CAD | -472.92% |
| 2023 Q4 | -2.35 Million CAD | -39.86% |
| 2023 Q3 | -1.68 Million CAD | 47.36% |
| 2023 FY | - CAD | 24.76% |
| 2022 FY | - CAD | 21.02% |
| 2022 Q2 | -5 Million CAD | 14.7% |
| 2022 Q3 | -3.8 Million CAD | 24.04% |
| 2022 Q4 | -768 Thousand CAD | 79.82% |
| 2022 Q1 | -5.87 Million CAD | -158.16% |
| 2021 Q3 | -15.02 Million CAD | 13.21% |
| 2021 FY | - CAD | -44.85% |
| 2021 Q1 | 2.68 Million CAD | 124.9% |
| 2021 Q2 | -17.31 Million CAD | -745.64% |
| 2021 Q4 | 10.09 Million CAD | 167.18% |
| 2020 FY | - CAD | -25.13% |
| 2020 Q1 | -6.14 Million CAD | -57.98% |
| 2020 Q4 | -10.77 Million CAD | -1945.99% |
| 2020 Q2 | 2.9 Million CAD | 147.17% |
| 2020 Q3 | 583.44 Thousand CAD | -79.89% |
| 2019 FY | - CAD | -575.5% |
| 2019 Q3 | -3.45 Million CAD | -16.59% |
| 2019 Q2 | -2.96 Million CAD | -703.22% |
| 2019 Q1 | 491.9 Thousand CAD | 332.68% |
| 2019 Q4 | -3.89 Million CAD | -12.51% |
| 2018 FY | - CAD | -156.84% |
| 2018 Q4 | -211.41 Thousand CAD | 14.48% |
| 2018 Q3 | -247.2 Thousand CAD | -55.68% |
| 2018 Q2 | -158.79 Thousand CAD | -138.68% |
| 2018 Q1 | 410.47 Thousand CAD | 352.88% |
| 2017 Q3 | -150.38 Thousand CAD | -59.16% |
| 2017 Q4 | -162.31 Thousand CAD | -7.93% |
| 2017 FY | - CAD | 26.17% |
| 2017 Q1 | -183.73 Thousand CAD | 9.87% |
| 2017 Q2 | -94.49 Thousand CAD | 48.57% |
| 2016 Q2 | 358.52 Thousand CAD | 339.05% |
| 2016 Q3 | -360.76 Thousand CAD | -200.62% |
| 2016 Q4 | -203.85 Thousand CAD | 43.49% |
| 2016 FY | - CAD | -655.04% |
| 2016 Q1 | -149.97 Thousand CAD | -0.81% |
| 2015 Q4 | -148.77 Thousand CAD | 15.19% |
| 2015 Q3 | -175.4 Thousand CAD | 14.79% |
| 2015 Q2 | -205.85 Thousand CAD | -18.75% |
| 2015 Q1 | -173.34 Thousand CAD | 2.09% |
| 2015 FY | - CAD | 87.1% |
| 2014 Q2 | -236.48 Thousand CAD | -7.92% |
| 2014 FY | - CAD | 10.14% |
| 2014 Q1 | -219.11 Thousand CAD | 23.1% |
| 2014 Q4 | -177.04 Thousand CAD | 42.71% |
| 2014 Q3 | -309.01 Thousand CAD | -30.67% |
| 2013 Q4 | -284.93 Thousand CAD | -28.14% |
| 2013 Q2 | -163.57 Thousand CAD | 13.21% |
| 2013 Q3 | -222.35 Thousand CAD | -35.94% |
| 2013 Q1 | -188.46 Thousand CAD | -28.83% |
| 2013 FY | - CAD | -54.0% |
| 2012 Q4 | -146.29 Thousand CAD | -15.27% |
| 2012 FY | - CAD | 32.51% |
| 2012 Q3 | -126.91 Thousand CAD | 24.68% |
| 2012 Q2 | -168.49 Thousand CAD | 17.1% |
| 2012 Q1 | -203.26 Thousand CAD | -10.82% |
| 2011 Q3 | -371.18 Thousand CAD | -68.3% |
| 2011 FY | - CAD | 4.47% |
| 2011 Q4 | -183.42 Thousand CAD | 50.58% |
| 2011 Q1 | -178.16 Thousand CAD | 35.45% |
| 2011 Q2 | -220.55 Thousand CAD | -23.79% |
| 2010 Q3 | -298.16 Thousand CAD | -7.39% |
| 2010 FY | - CAD | 51.11% |
| 2010 Q1 | -236.17 Thousand CAD | 79.63% |
| 2010 Q2 | -277.65 Thousand CAD | -17.56% |
| 2010 Q4 | -276.03 Thousand CAD | 7.42% |
| 2009 Q2 | -270.29 Thousand CAD | 14.01% |
| 2009 Q4 | -1.15 Million CAD | -273.26% |
| 2009 Q1 | -314.34 Thousand CAD | -628.71% |
| 2009 FY | - CAD | -78.6% |
| 2009 Q3 | -310.66 Thousand CAD | -14.93% |
| 2008 FY | - CAD | 46.39% |
| 2008 Q1 | -276.37 Thousand CAD | 27.87% |
| 2008 Q4 | 59.45 Thousand CAD | 116.83% |
| 2008 Q3 | -353.23 Thousand CAD | 70.44% |
| 2008 Q2 | -1.19 Million CAD | -332.42% |
| 2007 Q1 | -56.25 Thousand CAD | 26.89% |
| 2007 FY | - CAD | -392.3% |
| 2007 Q4 | -383.14 Thousand CAD | -76.19% |
| 2007 Q3 | -217.45 Thousand CAD | -4.83% |
| 2007 Q2 | -207.44 Thousand CAD | -268.77% |
| 2006 Q4 | -76.94 Thousand CAD | 4.03% |
| 2006 FY | - CAD | 4.93% |
| 2006 Q1 | -117.81 Thousand CAD | -580.13% |
| 2006 Q2 | -280.97 Thousand CAD | -138.5% |
| 2006 Q3 | -80.17 Thousand CAD | 71.46% |
| 2005 FY | - CAD | -128.57% |
| 2005 Q1 | -437.02 Thousand CAD | -562.25% |
| 2005 Q2 | -63.55 Thousand CAD | 85.46% |
| 2005 Q3 | -26.53 Thousand CAD | 58.25% |
| 2005 Q4 | -17.32 Thousand CAD | 34.71% |
| 2004 Q3 | -35.14 Thousand CAD | 3.31% |
| 2004 Q4 | -65.99 Thousand CAD | -87.75% |
| 2004 Q2 | -36.35 Thousand CAD | -133.1% |
| 2004 Q1 | -15.59 Thousand CAD | -2.6% |
| 2004 FY | - CAD | -1576.28% |
| 2003 FY | - CAD | 118.71% |
| 2003 Q4 | -15.2 Thousand CAD | 5.6% |
| 2003 Q3 | -16.1 Thousand CAD | 16.66% |
| 2003 Q2 | -19.32 Thousand CAD | 14.24% |
| 2003 Q1 | -22.52 Thousand CAD | 12.53% |
| 2002 Q1 | -35.89 Thousand CAD | 15.08% |
| 2002 FY | - CAD | 57.74% |
| 2002 Q2 | -23.59 Thousand CAD | 34.28% |
| 2002 Q4 | -25.75 Thousand CAD | -906.45% |
| 2002 Q3 | -2559.00 CAD | 89.15% |
| 2001 Q2 | -64.91 Thousand CAD | -29.65% |
| 2001 Q3 | -64.1 Thousand CAD | 1.25% |
| 2001 FY | - CAD | 7.84% |
| 2001 Q4 | -42.27 Thousand CAD | 34.06% |
| 2001 Q1 | -50.06 Thousand CAD | -46.9% |
| 2000 Q4 | -34.08 Thousand CAD | -10.28% |
| 2000 FY | - CAD | -57.27% |
| 2000 Q3 | -30.9 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 43.38% |
| 1998 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 154.025% |
| Avicanna Inc. | -7.35 Million CAD | -50.378% |
| Avant Brands Inc. | 4.83 Million CAD | 328.722% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | 60.326% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 24680.0% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 127.046% |
| MediPharm Labs Corp. | -10.47 Million CAD | -5.564% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 94.672% |
| Canopy Growth Corporation | -312.82 Million CAD | 96.464% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | -2.18% |